A Study of Combination Caplet With Loperamide Hydrochloride and Simethicone, and Imodium Express Tablets-lyophilizate Coadministered With Espumisan Capsule in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 5, 2019

Primary Completion Date

December 26, 2019

Study Completion Date

December 26, 2019

Conditions
Healthy
Interventions
DRUG

Combination Caplet with Loperamide HCl and Simethicone

Participants will receive combination caplet with loperamide HCl 2 mg and simethicone 125 mg as Test product A per assigned treatment sequence.

DRUG

Loperamide HCl

Participants will receive loperamide HCl 2 mg tablet-lyophilizate orally as part of Reference product B per assigned treatment sequence.

DRUG

Simethicone

Participants will receive Simethicone 40 mg capsule orally as part of Reference product B per assigned treatment sequence.

Trial Locations (1)

196143

"Scientific and Research centre Eco-safety Limited Liability Company", Saint Petersburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

McNeil AB

INDUSTRY